Preview

Bashkortostan Medical Journal

Advanced search

SELECTION AND BIOPHARMACEUTICAL STUDY OF AUXILIARY COMPOSITIONS FOR SOME INTRANASAL AND TRANSDERMAL DOSAGE FORMS

Abstract

An important task in the design of drugs for intranasal use is the choice of the type of dosage form and excipients. We settled on a soft medicinal formgel.Purpose: to select substances from all possible components of gels to create a dosage form with the ginkgo biloba phytocomplex and to study the possibility of creating gel structures that include the synthetic object nifedipine.Material and methods. Methods of molecular modeling and quantum chemistry involving elements of cluster analysis were used for theoretical research. For the confirmation experiment, the method of diffusion into a 2% agar gel with ferric oxide chlorideand the method of equilibrium dialysis through a semipermeable membrane. The selected active model is a well-known phytopreparation, obtained ginkgo biloba extract, as a dosage formgel.Results and discussion. The geometrical and electronic structure of 12 objects (in hydrate form and in vacuum) is characterized.Precision physico-chemical descriptors characterizing the affinity of all components of gels to each other are calculated: hydration heat, ionization potential, specific hydration, heat of formation, dipole moment, energy of the highest occupied molecular orbital, energy of the lower vacant molecular orbital, reactivity and stability indices (chemical rigidity and chemical potential).Conclusions. The theoretical search made it possible to reduce and concentrate the confirmatory experiment, which was traditionally performed using biopharmaceutical techniques in vitro, synthetic object nifedipine.

About the Authors

E. F. Stepanova
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


E. V. Kovtun
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


L. V. Pogrebnyak
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


A. B. Samoryadova
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


A. V. Pogrebnyak
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


V. V. Tokaev
Пятигорский медико-фармацевтический институт - филиал ФГБОУ ВО ВолгГМУ Минздрава России
Russian Federation


E. V. Morozova
ФГБОУ ВО «Северо-Осетинский государственный университет им. К.Л. Хетагурова»
Russian Federation


References

1. Allaert, F.A. Effect of NaCl + Chitosan 3% vs. NaCl on high blood pressure parameters of healthy volunteers with prehypertension / F.A. Allaert // Minerva Cardioangiol. - 2017. - Vol. 65, № 6. - P. 563-576.

2. Chitin and chitosan as tools to combat COVID-19: a triple approach / M. Safarzadeh [et al.] // Int. J. Biol. Macromol. - 2021. - Vol. 183. - P. 235-244.

3. Stewart, J.J.P. Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and reoptimization of parameters /j.J.P. Stewart //j. Mol. Model. - 2013. - Vol. 19, № 1. - P. 1-32.

4. Klamt, А. COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient / А. Klamt, G. Schüürmann //j. Chem. Soc., Perkin Trans. 2. - 1993. - P. 799-805.

5. Parr, R.G. Electrophilicity index / R.G. Parr, L.V. Szentpaly, S. Liu //j. Am. Chem. Soc. - 1999. - Vol. 121, № 9. - P. 1922-1924.

6. Анурова, М.Н. Мягкие лекарственные формы: типы, характеристики, регламентация / М.Н. Анурова, Н.Б. Демина // Фармация. - 2014. - № 8. - С. 44-48.

7. Изучение интенсивности высвобождения миноксидила из мазевых основ / В.В. Гладышев [и др.] // Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. - 2014. - № 24. - С. 242-245.

8. Камаева, С.С. Влияние основы на высвобождение резорцина из мазей / С.С. Камаева, Г.Ю. Меркурьева, Н.В. Тарасова // Здоровье - основа человеческого потенциала: проблемы и пути решения. - 2012. - Т. 7, № 2. - С. 844-845.

9. Ляпунов, А.Н. Исследование высвобождения мелоксикама из мягких лекарственных средств в опытах in vitro методом диализа через полупроницаемую мембрану / А.Н. Ляпунов, Е.П. Безуглая, Н.А. Ляпунов // Фармаком. - 2016. - № 2. - С. 33-42.

10. Илиев, К.И. Биофармацевтические и фармакологические исследования мази «Лидодиклозоль» / К.И. Илиев, Н.Н. Бачева, Л.П. Ларионов // Медицинская наука и образование Урала. - 2016. - Т. 17, № 2. - С. 127-131.

11. Bartosova, L. Transdermal drug delivery in vitro using diffusion cells / L. Bartosova, J. Bajgar // Curr. Med. Chem. - 2012. - Vol. 19, № 27. - P. 4671-4677.

12. Olejnik, A. Active compounds release from semisolid dosage forms / A. Olejnik, J. Goscianska, I. Nowak //j. Pharm. Sci. - 2012. - Vol. 101, № 11. - P. 4032-4045.

13. The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study / S.F. Ng [et al.] // Arch. Pharm. Res. - 2012. - Vol. 35, № 4. - P. 579-593.

14. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cells / S.F. Ng [et al.] // Pharmaceutics. - 2010. - Vol. 2, № 2. - P. 209-223.

15. Franz diffusion cell approach for preformulation characterisation of ketoprofen semisolid dosage forms / C.H. Salamanca [et al.] // Pharmaceutics. - 2018. - Vol. 10, № 3. - P. 148.


Review

For citations:


Stepanova E.F., Kovtun E.V., Pogrebnyak L.V., Samoryadova A.B., Pogrebnyak A.V., Tokaev V.V., Morozova E.V. SELECTION AND BIOPHARMACEUTICAL STUDY OF AUXILIARY COMPOSITIONS FOR SOME INTRANASAL AND TRANSDERMAL DOSAGE FORMS. Bashkortostan Medical Journal. 2022;17(2):40-46. (In Russ.)

Views: 101


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1999-6209 (Print)